Cargando…
Evaluation of neutralizing antibodies after vaccine BNT162b2: Preliminary data
It is well-known that the Coronavirus Disease 2019, which is caused by the beta-coronavirus severe acute respiratory syndrome (SARS-CoV-2), emerged in December 2019 followed by an outbreak first reported in Wuhan, China. Thus far, vaccination appears to be the only way to bring the pandemic to an en...
Autores principales: | Vietri, Maria Teresa, Albanese, Luisa, Passariello, Luana, D'Elia, Giovanna, Caliendo, Gemma, Molinari, Anna Maria, Angelillo, Italo Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670104/ https://www.ncbi.nlm.nih.gov/pubmed/34923323 http://dx.doi.org/10.1016/j.jcv.2021.105057 |
Ejemplares similares
-
Antibody levels after BNT162b2 vaccine booster and SARS-CoV-2 Omicron infection
por: Vietri, Maria Teresa, et al.
Publicado: (2022) -
Diagnostic utility of FGF-23 in mineral bone disorder during chronic kidney disease
por: Albanese, Luisa, et al.
Publicado: (2022) -
Hereditary Cancer Syndrome in a Family with Double Mutation in BRIP1 and MUTYH Genes
por: D’Elia, Giovanna, et al.
Publicado: (2023) -
Increased Risk of Hereditary Prostate Cancer in Italian Families with Hereditary Breast and Ovarian Cancer Syndrome Harboring Mutations in BRCA and in Other Susceptibility Genes
por: D’Elia, Giovanna, et al.
Publicado: (2022) -
Hereditary Prostate Cancer: Genes Related, Target Therapy and Prevention
por: Vietri, Maria Teresa, et al.
Publicado: (2021)